NCT04897321 2026-04-15B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)St. Jude Children's Research HospitalPhase 1 Recruiting48 enrolled
NCT05849662 2026-04-15A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic LeukemiaTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1/2 Recruiting58 enrolled
NCT04119024 2026-03-17Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsStanford UniversityPhase 1 Recruiting18 enrolled
NCT06186401 2026-03-16Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T CellsUniversity of California, San FranciscoPhase 1 Recruiting20 enrolled